Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ITPKA Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA559185
Description
Immunogen sequence: DGSCSTDFKT TRSREQVLRV FEEFVQGDEE VLRRYLNRLQ QIRDTLEVSE FFRRHEV Highest antigen sequence identity to the following orthologs: Mouse - 91%, Rat - 89%.
Regulates inositol phosphate metabolism by phosphorylation of second messenger inositol 1,4,5-trisphosphate to Ins(1,3,4,5)P4. The activity of the inositol 1,4,5-trisphosphate 3-kinase is responsible for regulating the levels of a large number of inositol polyphosphates that are important in cellular signaling. Both calcium/calmodulin and protein phosphorylation mechanisms control its activity. It is also a substrate for the cyclic AMP-dependent protein kinase, calcium/calmodulin- dependent protein kinase II, and protein kinase C in vitro.
Specifications
ITPKA | |
Polyclonal | |
Unconjugated | |
ITPKA | |
EC 2.7.1.127; inositol 1,4,5-triphosphate 3-kinase; inositol 1,4,5-trisphosphate 3-kinase A; inositol 145-triphosphate 3-kinase; inositol-trisphosphate 3-kinase A; insP 3-kinase A; IP3 3 kinase A; IP3 3-kinase A; IP3-3KA; IP3K A; IP3KA; IP3-kinase A; ITPKA | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
3706 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot, Immunocytochemistry, Western Blot | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
P23677 | |
ITPKA | |
Recombinant protein corresponding to Human ITPKA. Recombinant protein control fragment (Product #RP-98080). | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction